Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into Account.

Elena Gonzalez-Rodriguez Bérengère Aubry-Rozier Delphine Stoll Khalil Zaman Olivier Lamy

J Clin Oncol

Elena Gonzalez-Rodriguez, MD, PhD, Center of Bone Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland; Bérengère Aubry-Rozier, MD and Delphine Stoll, MD, Center of Bone Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland; Khalil Zaman, MD, PhD, Breast Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland; and Olivier Lamy, MD, Center of Bone Diseases, Lausanne University Hospital, University of Lausanne, and Service of Internal Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Published: May 2020

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO.19.02678	DOI Listing

Publication Analysis

Top Keywords

increased risk

risk multiple

multiple spontaneous

spontaneous vertebral

vertebral fractures

fractures denosumab

denosumab discontinuation

discontinuation account

increased

multiple

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!